Viridian Therapeutics wins FDA approval for lumvoa.

Viridian Therapeutics announced the FDA approval and immediate launch of Lumvoa for thyroid eye disease. This makes Lumvoa the first approved treatment for both active and chronic TED and represents a major milestone for the company.